SEC Filings | Biora Therapeutics, Inc.

Filing date	Form	Description	Filing Group	View
December 1, 2020	S-1	Registration statement for face-amount certificate companies	Registration statements	View HTML 0001193125-20-305933.pdf 0001193125-20-305933.rtf 0001193125-20-305933.xls EX-101.INS - XBRL INSTANCE DOCUMENT
March 19, 2021	S-1	Registration statement for face-amount certificate companies	Registration statements	View HTML 0001193125-21-086045.pdf 0001193125-21-086045.rtf 0001193125-21-086045.xls
June 18, 2021	S-1	Registration statement for face-amount certificate companies	Registration statements	View HTML 0001193125-21-193503.pdf 0001193125-21-193503.rtf 0001193125-21-193503.xls
November 10, 2022	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy filings	View HTML 0001140361-22-041006.pdf 0001140361-22-041006.rtf 0001140361-22-041006.xls
April 12, 2024	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy filings	View HTML 0001193125-24-094754.pdf 0001193125-24-094754.rtf 0001193125-24-094754.xls
June 18, 2020	FWP	FWP	Other	View HTML 0001193125-20-171832.pdf 0001193125-20-171832.rtf
December 3, 2020	FWP	FWP	Other	View HTML 0001193125-20-308852.pdf 0001193125-20-308852.rtf 0001193125-20-308852.xls
June 18, 2020	EFFECT	EFFECT	Other	View HTML 9999999995-20-001475.pdf 9999999995-20-001475.rtf 9999999995-20-001475.xls
December 2, 2020	EFFECT	EFFECT	Other	View HTML 9999999995-20-003385.pdf 9999999995-20-003385.rtf 9999999995-20-003385.xls
April 1, 2021	EFFECT	EFFECT	Other	View HTML 9999999995-21-001255.pdf 9999999995-21-001255.rtf 9999999995-21-001255.xls

Data provided by Kaleidoscope.